iSpecimen Inc. 8-K

What Happened
iSpecimen Inc. (ISPC) filed an 8-K on June 1, 2026, reporting that on May 29, 2026 Nasdaq’s Listing Qualifications Department notified the company it does not comply with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000 for continued listing on the Nasdaq Capital Market. The company reported stockholders’ equity of $814,038 as of its Quarterly Report on Form 10‑Q for the period ended March 31, 2026. The notice does not immediately affect trading of ISPC, which continues to trade on Nasdaq.

Key Details

• Nasdaq cited noncompliance with Rule 5550(b)(1) (minimum $2,500,000 stockholders’ equity).
• iSpecimen reported stockholders’ equity of $814,038 as of March 31, 2026.
• As of May 29, 2026, the company did not meet alternative continued-listing standards (equity, market value of listed securities, or net income).
• The company has 45 calendar days from the notice (May 29, 2026) to submit a compliance plan; if Nasdaq accepts the plan, an extension of up to 180 days may be granted. The company intends to submit a plan and may appeal any adverse decision to a Nasdaq Hearings Panel.

Why It Matters
A Nasdaq notice for failure to meet listing requirements is material because it creates the risk of potential delisting if the company cannot demonstrate a credible path to compliance. For investors, this raises near-term uncertainty about the stock’s listing status and could affect liquidity and access to institutional investors. iSpecimen’s next public filing(s) and any Nasdaq response to its compliance plan will be key updates to watch.